Verition Fund Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History
Bought
Maintained
Sold
Verition Fund Management's DALS Position: Q3 2023 in Review
Verition Fund Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 128,120 shares — an estimated $1.31M sold.
Verition Fund Management first reported a position in DALS in Q1 2022 and held it in 6 quarters. The position peaked at $1.31M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.
- Verition Fund Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
- Verition Fund Management sold 128,120 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $1.31M.
- Verition Fund Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q1 2022 and held it in 6 quarters.
- Verition Fund Management's DA32 Life Science Tech Acquisition Corp position peaked at $1.31M in Q2 2023.
- 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.
Based on Verition Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.